A Stable Upstream Stem-loop Structure Enhances Selection of the First 5'-ORF-AUG as a Main Start Codon for Translation Initiation of Human ACAT1 mRNA

Acyl-coenzyme A:cholesterol acyltransferase (ACAT)is an integral membrane protein, which is mainly locatedin rough endoplasmic reticulum (ER), and is responsiblefor catalyzing the intracellular formation of cholesterylester from cholesterol and long-chain fatty acyl-coenzymeA [1,2]. Human ACAT1 cDNA K1 was firstly cloned andfunctionally expressed in 1993 [3]. Further studies withspecific anti-ACAT1 antibody (DM10) illustrated that onemajor 50 kD ACAT1 protein was expressed in various…     

绿豆插条生根过程中内源激素含量变化

绿豆插条离体后其IAA含量出现一个峰值,乙烯利处理的IAA峰值出现在第6小时,未经乙烯利处理的出现在第12小时,与插条生根峰出现时间相符.乙烯利处理与否的插条生根过程中,内源GA3含量在0～30h内呈下降趋势,随后略微上升;内源ABA含量先升后降;细胞分裂素ZT和ZR含量在总体上是下降的.     

不同基肥对退化坡地及牧草产量和质量的影响

探讨了不同基肥组合处理对退化坡地的改造利用和对牧草生产的影响．在相同的肥水管理条件下,以“鸡粪＋牛粪＋石灰”的基肥组合（Ａ）处理退化坡地土壤,可使皇草、杂交狼尾草、矮象草和墨西哥玉米的年产量比“猪粪＋牛粪＋石灰”的组合（Ｂ）处理分别高出９．７％、１２．８％、４３．０％和９．９％,前者（Ａ）生产出的牧草的粗蛋白含量略高于后者（Ｂ）,粗纤维含量略低于后者,而粗灰分含量显著高于后者．     

测定结肠粘膜菌群变化对大肠癌的早期诊断辅助性的研究

测定结肠粘膜菌群变化对大肠癌的早期诊断辅助性的研究佳木斯医学院附属医院腔镜室佳木斯１５４００２孙玉清佳木斯医学院生理教研室吕密凯佳木斯医学院微生物教研室李丽秋马淑霞杨景云大肠癌是常见的恶性肿瘤之一,许多资料表明发病率逐年上升。病因及发病机理不清,有关...     

中国点池蝇属一新种：双翅目：蝇科

本文记述我国点池蝇属１新种：山西点池蝇Ｓｐｉｌｏｇｏｎａｓｈａｎｘｉｅｎｓｉｓｓｐ．ｎｏｖ．。     

环境光对哺乳动物昼夜节律和大脑功能的影响

昼夜循环对人类和其他动物的生理和行为有着巨大的影响。光照条件能影响动物的视觉成像,并通过向大脑中的生物钟中心发送信号来调整生理和行为的节律。环境光向生物钟传递信号的系统包含了一个复杂的神经递质复合体-受体-第二信使系统。在夜间曝光能迅速启动下丘脑视交叉上核中大量相关的早期基因。此外,许多白天活动的物种,通常都是在光照条件下获得认知。本文综述了环境光对哺乳动物睡眠、生物节律、大脑认知能力和基因表达等生理和行为方面的影响。     

HIV Shedding from Male Circumcision Wounds in HIV-Infected Men: A Prospective Cohort Study

BackgroundA randomized trial of voluntary medical male circumcision (MC) of HIV—infected men reported increased HIV transmission to female partners among men who resumed sexual intercourse prior to wound healing. We conducted a prospective observational study to assess penile HIV shedding after MC.ConclusionPenile HIV shedding is significantly reduced after healing of MC wounds. Lower plasma VL is associated with decreased frequency and quantity of HIV shedding from MC wounds. Starting ART prior to MC should be considered to reduce male-to-female HIV transmission risk. Research is needed to assess the time on ART required to decrease shedding, and the acceptability and feasibility of initiating ART at the time of MC.     

Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies

Background

Few estimates exist of the life expectancy of HIV-positive adults receiving antiretroviral treatment (ART) in low- and middle-income countries. We aimed to estimate the life expectancy of patients starting ART in South Africa and compare it with that of HIV-negative adults.

Methods and Findings

Data were collected from six South African ART cohorts. Analysis was restricted to 37,740 HIV-positive adults starting ART for the first time. Estimates of mortality were obtained by linking patient records to the national population register. Relative survival models were used to estimate the excess mortality attributable to HIV by age, for different baseline CD4 categories and different durations. Non-HIV mortality was estimated using a South African demographic model. The average life expectancy of men starting ART varied between 27.6 y (95% CI: 25.2–30.2) at age 20 y and 10.1 y (95% CI: 9.3–10.8) at age 60 y, while estimates for women at the same ages were substantially higher, at 36.8 y (95% CI: 34.0–39.7) and 14.4 y (95% CI: 13.3–15.3), respectively. The life expectancy of a 20-y-old woman was 43.1 y (95% CI: 40.1–46.0) if her baseline CD4 count was ≥200 cells/µl, compared to 29.5 y (95% CI: 26.2–33.0) if her baseline CD4 count was <50 cells/µl. Life expectancies of patients with baseline CD4 counts ≥200 cells/µl were between 70% and 86% of those in HIV-negative adults of the same age and sex, and life expectancies were increased by 15%–20% in patients who had survived 2 y after starting ART. However, the analysis was limited by a lack of mortality data at longer durations.

Conclusions

South African HIV-positive adults can have a near-normal life expectancy, provided that they start ART before their CD4 count drops below 200 cells/µl. These findings demonstrate that the near-normal life expectancies of HIV-positive individuals receiving ART in high-income countries can apply to low- and middle-income countries as well. Please see later in the article for the Editors'' Summary